Significant Improvement in Clinical Symptoms and Quality of Life of Coronary Heart Disease with Diabetes Mellitus Patients Treated with EECP Therapy
Coronary heart disease and diabetes mellitus are the most common cause of mortality around the world. Health
related quality of life assessment is an important tool to measure the effect of a treatment. Seattle Angina Questionnaire
(SAQ) is a valid and reliable tool to assess the effectiveness of an intervention or treatment on quality of life of coronary
heart disease (CHD) patients. This study aim was to assess the effect of EECP (Enhanced External Counter Pulsation)
therapy on disease-specific quality of life along with clinical symptoms of diabetic and non diabetic coronary heart disease
patients. This prospective observational study was conducted on coronary heart disease with and without diabetes mellitus
patients (n=200) referred to SAAOL heart center, Delhi-NCR, India. The study subjects were divided into two groups.
Coronary heart disease with diabetes mellitus enrolled in the first group and patient having only coronary heart disease
without diabetes mellitus were enrolled into the second group. Disease-specific quality of life of study subjects was
measured by Seattle angina questionnaire and clinical symptoms of the subjects were evaluated by CCS (Canadian
Cardiovascular Society Grading) angina scale and MRC (Medical Research Council), dyspnoea scale. The results of the
study analyzed through SPSS software and mean, SD, paired sample t – test, P-value were evaluated at pre and post EECP
assessment. This study showed significant improvement in angina class and dyspnea score along with improvement in the
quality of life of diabetic and non diabetic coronary heart disease patients after EECP therapy.
Index terms - Quality of Life, Coronary Heart Disease, EECP (Enhanced External Counter Pulsation)